Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Midday movers: McDonald's, Southwest Airlines, General Motors and more

Published 10/30/2023, 08:04 AM
Updated 10/30/2023, 01:14 PM
© Reuters.
GM
-
F
-
CSCO
-
MCD
-
LUV
-
HSBC
-

Investing.com -- U.S. shares were rising on Monday to start a full week of earnings reports as investors look ahead to the next interest rate decision from the Federal Reserve.

Here are some of the biggest U.S. stock movers today:

  • McDonald's (NYSE:MCD) stock rose 1.8% after the burger giant beat estimates for third-quarter profit and sales on Monday, and also raised its quarterly cash dividend by 10%, powered by new launches as well as steady demand for its cheaper burgers and fries from diners struggling with still-high food prices.

  • Southwest Airlines (NYSE:LUV) stock rose 0.1%, rebounding from Friday’s sharp losses, despite the carrier stating that the U.S. transportation regulator may impose a fine related to the wide-scale operational disruptions the carrier faced in December last year.

  • Ford (NYSE:F) stock fell 1.3% after the car making giant reached a tentative labor deal with the United Auto Workers union that would end long-standing strikes at some of the company's plants. General Motors Company (NYSE:GM) shares rose 0.2% after also reaching an agreement, and Stellantis NV (NYSE:STLA) dipped 0.1%.

  • HSBC (NYSE:HSBC) ADRs stock fell 1.9% after the banking giant unveiled an extra $3 billion in share buybacks, bringing its total returns to shareholders this year to $7B, after reporting pretax profit in the third quarter of $7.7B, jumping from $4.5B in the corresponding period last year.

  • Cisco (NASDAQ:CSCO) stock fell 0.4% after Raymond James downgraded the tech company to ‘market perform’ from ‘outperform’, expecting the company to experience a decline in campus sales, which are likely responsible for approximately one-third of the sales decline expected in 2024.

  • Coherus Biosciences (NASDAQ:CHRS) stock jumped over 14% after the U.S. health regulator approved the biotech's treatment for nasopharyngeal cancer.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.